What is Northland Capmk’s Estimate for Arteris Q1 Earnings?

Arteris, Inc. (NASDAQ:AIPFree Report) – Research analysts at Northland Capmk issued their Q1 2026 earnings estimates for shares of Arteris in a research note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard forecasts that the company will earn ($0.14) per share for the quarter. The consensus estimate for Arteris’ current full-year earnings is ($0.71) per share. Northland Capmk also issued estimates for Arteris’ Q2 2026 earnings at ($0.11) EPS, Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The business had revenue of $15.49 million during the quarter, compared to analyst estimates of $15.34 million.

Several other equities research analysts have also commented on the company. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research report on Tuesday, February 18th. Northland Securities upped their price objective on Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Wednesday.

View Our Latest Stock Analysis on Arteris

Arteris Price Performance

Shares of NASDAQ:AIP opened at $9.28 on Friday. Arteris has a twelve month low of $5.76 and a twelve month high of $12.64. The company’s 50 day moving average is $10.53 and its 200 day moving average is $8.74. The company has a current ratio of 1.17, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The company has a market cap of $380.02 million, a PE ratio of -10.67 and a beta of 1.18.

Insiders Place Their Bets

In other news, CEO K Charles Janac sold 60,584 shares of the stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $10.42, for a total transaction of $631,285.28. Following the transaction, the chief executive officer now owns 10,134,541 shares in the company, valued at $105,601,917.22. This trade represents a 0.59 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Nicholas B. Hawkins sold 5,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $8.56, for a total value of $42,800.00. Following the transaction, the chief financial officer now owns 190,414 shares in the company, valued at $1,629,943.84. This trade represents a 2.56 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 367,157 shares of company stock worth $3,828,388. Corporate insiders own 33.70% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. PVG Asset Management Corp purchased a new position in shares of Arteris during the 4th quarter valued at approximately $151,000. PharVision Advisers LLC purchased a new position in shares of Arteris during the 4th quarter valued at approximately $173,000. Squarepoint Ops LLC purchased a new position in shares of Arteris during the 4th quarter valued at approximately $160,000. Two Sigma Advisers LP lifted its position in shares of Arteris by 82.9% during the 4th quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock valued at $240,000 after buying an additional 10,700 shares in the last quarter. Finally, Two Sigma Investments LP lifted its holdings in Arteris by 166.0% in the 4th quarter. Two Sigma Investments LP now owns 60,533 shares of the company’s stock valued at $617,000 after purchasing an additional 37,772 shares in the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Earnings History and Estimates for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.